BACKGROUND: The ability of echocardiographic dyssynchrony to predict response to cardiac resynchronization therapy (CRT) has been unclear. METHODS AND RESULTS: A prospective, longitudinal study was designed with predefined dyssynchrony indexes and outcome variables to test the hypothesis that baseline dyssynchrony is associated with long-term survival after CRT. We studied 229 consecutive class III to IV heart failure patients with ejection fraction ≤35 and QRS duration ≥120 milliseconds for CRT. Dyssynchrony before CRT was defined as tissue Doppler velocity opposing-wall delay ≥65 milliseconds, 12-site SD (Yu Index) ≥32 milliseconds, speckle tracking radial strain anteroseptal-to-posterior wall delay ≥130 milliseconds, or pulsed Doppler interventricular mechanical delay ≥40 milliseconds. Outcome was defined as freedom from death, heart transplantation, or left ventricular assist device implantation. Of 210 patients (89) with dyssynchrony data available, there were 62 events: 47 deaths, 9 transplantations, and 6 left ventricular assist device implantations over 4 years. Event-free survival was associated with Yu Index (P=0.003), speckle tracking radial strain (P=0.003), and interventricular mechanical delay (P=0.019). When adjusted for confounding baseline variables of ischemic origin and QRS duration, Yu Index and radial strain dyssynchrony remained independently associated with outcome (P<0.05). Lack of radial dyssynchrony was particularly associated with unfavorable outcome in those with QRS duration of 120 to 150 milliseconds (P=0.002). CONCLUSIONS: The absence of echocardiographic dyssynchrony was associated with significantly less favorable event-free survival after CRT. Patients with narrower QRS duration who lacked dyssynchrony had the least favorable long-term outcome. These observations support the relationship of dyssynchrony and CRT response.
BACKGROUND: The ability of echocardiographic dyssynchrony to predict response to cardiac resynchronization therapy (CRT) has been unclear. METHODS AND RESULTS: A prospective, longitudinal study was designed with predefined dyssynchrony indexes and outcome variables to test the hypothesis that baseline dyssynchrony is associated with long-term survival after CRT. We studied 229 consecutive class III to IV heart failurepatients with ejection fraction ≤35 and QRS duration ≥120 milliseconds for CRT. Dyssynchrony before CRT was defined as tissue Doppler velocity opposing-wall delay ≥65 milliseconds, 12-site SD (Yu Index) ≥32 milliseconds, speckle tracking radial strain anteroseptal-to-posterior wall delay ≥130 milliseconds, or pulsed Doppler interventricular mechanical delay ≥40 milliseconds. Outcome was defined as freedom from death, heart transplantation, or left ventricular assist device implantation. Of 210 patients (89) with dyssynchrony data available, there were 62 events: 47 deaths, 9 transplantations, and 6 left ventricular assist device implantations over 4 years. Event-free survival was associated with Yu Index (P=0.003), speckle tracking radial strain (P=0.003), and interventricular mechanical delay (P=0.019). When adjusted for confounding baseline variables of ischemic origin and QRS duration, Yu Index and radial strain dyssynchrony remained independently associated with outcome (P<0.05). Lack of radial dyssynchrony was particularly associated with unfavorable outcome in those with QRS duration of 120 to 150 milliseconds (P=0.002). CONCLUSIONS: The absence of echocardiographic dyssynchrony was associated with significantly less favorable event-free survival after CRT. Patients with narrower QRS duration who lacked dyssynchrony had the least favorable long-term outcome. These observations support the relationship of dyssynchrony and CRT response.
Authors: Jeroen J Bax; Theodore Abraham; S Serge Barold; Ole A Breithardt; Jeffrey W H Fung; Stephane Garrigue; John Gorcsan; David L Hayes; David A Kass; Juhani Knuuti; Christophe Leclercq; Cecilia Linde; Daniel B Mark; Mark J Monaghan; Petros Nihoyannopoulos; Martin J Schalij; Christophe Stellbrink; Cheuk-Man Yu Journal: J Am Coll Cardiol Date: 2005-12-20 Impact factor: 24.094
Authors: Maxime Cannesson; Masaki Tanabe; Matthew S Suffoletto; David Schwartzman; John Gorcsan Journal: Am J Cardiol Date: 2006-08-15 Impact factor: 2.778
Authors: Shajil Chalil; Berthold Stegemann; Sarkaw Muhyaldeen; Kayvan Khadjooi; Russell E A Smith; Paul J Jordan; Francisco Leyva Journal: J Am Coll Cardiol Date: 2007-06-29 Impact factor: 24.094
Authors: John Gorcsan; Masaki Tanabe; Gabe B Bleeker; Matthew S Suffoletto; Nini C Thomas; Samir Saba; Laurens F Tops; Martin J Schalij; Jeroen J Bax Journal: J Am Coll Cardiol Date: 2007-09-24 Impact factor: 24.094
Authors: Gabe B Bleeker; Theodorus A M Kaandorp; Hildo J Lamb; Eric Boersma; Paul Steendijk; Albert de Roos; Ernst E van der Wall; Martin J Schalij; Jeroen J Bax Journal: Circulation Date: 2006-02-13 Impact factor: 29.690
Authors: John Gorcsan; Theodore Abraham; Deborah A Agler; Jeroen J Bax; Genevieve Derumeaux; Richard A Grimm; Randy Martin; Jonathan S Steinberg; Martin St John Sutton; Cheuk-Man Yu Journal: J Am Soc Echocardiogr Date: 2008-03 Impact factor: 5.251
Authors: Matthew Richardson; Nick Freemantle; Melanie J Calvert; John G F Cleland; Luigi Tavazzi Journal: Eur Heart J Date: 2007-05-31 Impact factor: 29.983
Authors: Dominique Auger; Gabe B Bleeker; Matteo Bertini; See H Ewe; Rutger J van Bommel; Tomasz G Witkowski; Arnold C T Ng; Lieselot van Erven; Martin J Schalij; Jeroen J Bax; Victoria Delgado Journal: Eur Heart J Date: 2012-01-24 Impact factor: 29.983
Authors: Jonathan A Kirk; Ronald J Holewinski; Viola Kooij; Giulio Agnetti; Richard S Tunin; Namthip Witayavanitkul; Pieter P de Tombe; Wei Dong Gao; Jennifer Van Eyk; David A Kass Journal: J Clin Invest Date: 2014-01 Impact factor: 14.808